Reducing cardiovascular risk in the patient with elevated triglycerides

Speaker Name/Credentials

Alan S. Brown, M.D.

Director, Division of Cardiology and the Lipid Clinic Advocate Lutheran General Hospital Clinical Associate Professor, Loyola University Medical Center

Estimated Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min Q&A = 0.25 credits
Total = 1.0 credits


This webinar will cover clinical implications and therapeutic approaches to patients with hypertriglyceridemia.

This presentation was created and presented before the results of the REDUCE-IT trial were released.

Learning Objectives

1. Understand the effect of hypertriglyceridemia on CHD risk.

2. Review treatment strategies to reduce risk of pancreatitis and CHD events.

3. Review appropriate therapies for patients with elevated triglycerides.


Speaker  – Amgen, Regeneron, Sanofi, Advisory Board- Amarin, Kastle, Kowa, Pfizer, Sanofi

Share this: